Corrigendum to ‘Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial’ eClinicalMedicine 2026; 92: 103764
- DOI
- 10.1016/j.eclinm.2026.103834
- Published
- 2026-03
- Container
- eClinicalMedicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.eclinm.2026.103834,
title = {Corrigendum to ‘Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial’ eClinicalMedicine 2026; 92: 103764},
author = {Michael R. Lassen and Matthew Scarborough and Nigel Gilchrist and Shiva S. Tripathi and Cathy Price and Angel Horcajadas and Javier DeAndres and Ganesan Baranidharan and Sashin Ahuja and Kristian S. Otte and Emily Wood and Sarah Guest and Lloyd G. Czaplewski and Duncan McHale},
year = {2026},
journal = {eClinicalMedicine},
doi = {10.1016/j.eclinm.2026.103834},
url = {https://doi.org/10.1016/j.eclinm.2026.103834}
}RIS
TY - JOUR TI - Corrigendum to ‘Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial’ eClinicalMedicine 2026; 92: 103764 AU - Michael R. Lassen AU - Matthew Scarborough AU - Nigel Gilchrist AU - Shiva S. Tripathi AU - Cathy Price AU - Angel Horcajadas AU - Javier DeAndres AU - Ganesan Baranidharan AU - Sashin Ahuja AU - Kristian S. Otte AU - Emily Wood AU - Sarah Guest AU - Lloyd G. Czaplewski AU - Duncan McHale PY - 2026 JO - eClinicalMedicine DO - 10.1016/j.eclinm.2026.103834 UR - https://doi.org/10.1016/j.eclinm.2026.103834 ER -
APA
Lassen, M. R., Scarborough, M., Gilchrist, N., Tripathi, S. S., Price, C., Horcajadas, A., DeAndres, J., Baranidharan, G., Ahuja, S., Otte, K. S., Wood, E., Guest, S., Czaplewski, L. G., & McHale, D. (2026). Corrigendum to ‘Intradiscal linezolid (PP353) treatment for chronic low back pain associated with Modic change type 1: an international, first-in-human, randomised, sham procedure-controlled, double-blind, phase 1b clinical trial’ eClinicalMedicine 2026; 92: 103764. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.103834
Source records
- crossref · retrieved 2026-09-26T12:08:27.852Z